286 related articles for article (PubMed ID: 9188997)
1. Intranasal administration of midazolam: pharmacokinetic and pharmacodynamic properties and sedative potential.
Fukuta O; Braham RL; Yanase H; Kurosu K
ASDC J Dent Child; 1997; 64(2):89-98. PubMed ID: 9188997
[TBL] [Abstract][Full Text] [Related]
2. Comparing the safety, efficacy and recovery of intranasal midazolam vs. oral chloral hydrate and promethazine.
Dallman JA; Ignelzi MA; Briskie DM
Pediatr Dent; 2001; 23(5):424-30. PubMed ID: 11699169
[TBL] [Abstract][Full Text] [Related]
3. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
[TBL] [Abstract][Full Text] [Related]
4. A comparison of intranasal dexmedetomidine and oral midazolam for premedication in pediatric anesthesia: a double-blinded randomized controlled trial.
Yuen VM; Hui TW; Irwin MG; Yuen MK
Anesth Analg; 2008 Jun; 106(6):1715-21. PubMed ID: 18499600
[TBL] [Abstract][Full Text] [Related]
5. Midazolam increases bite force during intravenous sedation.
Huang MY; Matsuura N; Kaneko Y; Ichinohe T
J Oral Maxillofac Surg; 2012 Aug; 70(8):e458-63. PubMed ID: 22704364
[TBL] [Abstract][Full Text] [Related]
6. The role of patient-controlled apparatus for sedation in the emergency department.
Kekeç Z; Akin A; Kilinç S; Sözüer EM
Mt Sinai J Med; 2005 Nov; 72(6):385-8. PubMed ID: 16358163
[TBL] [Abstract][Full Text] [Related]
7. Sedative effects of midazolam and xylazine with or without ketamine and detomidine alone following intranasal administration in Ring-necked Parakeets.
Vesal N; Eskandari MH
J Am Vet Med Assoc; 2006 Feb; 228(3):383-8. PubMed ID: 16448361
[TBL] [Abstract][Full Text] [Related]
8. Intranasal dexmedetomidine vs midazolam for premedication in children undergoing complete dental rehabilitation: a double-blinded randomized controlled trial.
Sheta SA; Al-Sarheed MA; Abdelhalim AA
Paediatr Anaesth; 2014 Feb; 24(2):181-9. PubMed ID: 24237879
[TBL] [Abstract][Full Text] [Related]
9. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
[TBL] [Abstract][Full Text] [Related]
10. Comparison of oral ketamine and oral midazolam as sedative agents in pediatric dentistry.
Damle SG; Gandhi M; Laheri V
J Indian Soc Pedod Prev Dent; 2008 Sep; 26(3):97-101. PubMed ID: 18923220
[TBL] [Abstract][Full Text] [Related]
11. The safety and efficacy of intranasal dexmedetomidine during electrochemotherapy for facial vascular malformation: a double-blind, randomized clinical trial.
Zhang X; Bai X; Zhang Q; Wang X; Lu L
J Oral Maxillofac Surg; 2013 Nov; 71(11):1835-42. PubMed ID: 23945510
[TBL] [Abstract][Full Text] [Related]
12. Effect of submucosal midazolam on behavior and physiologic response when combined with oral chloral hydrate and nitrous oxide sedation.
Myers GR; Maestrello CL; Mourino AP; Best AM
Pediatr Dent; 2004; 26(1):37-43. PubMed ID: 15080356
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, crossover assessment of the sedative and analgesic effects of intranasal dexmedetomidine.
Yuen VM; Irwin MG; Hui TW; Yuen MK; Lee LH
Anesth Analg; 2007 Aug; 105(2):374-80. PubMed ID: 17646493
[TBL] [Abstract][Full Text] [Related]
14. Intranasal midazolam plasma concentration profile and its effect on anxiety associated with dental procedures.
Burstein AH; Modica R; Hatton M; Gengo FM
Anesth Prog; 1996; 43(2):52-7. PubMed ID: 10323126
[TBL] [Abstract][Full Text] [Related]
15. The sedative effects of intranasal midazolam administration in the dental treatment of patients with mental disabilities. Part 2: optimal concentration of intranasal midazolam.
Fukuta O; Braham RL; Yanase H; Kurosu K
J Clin Pediatr Dent; 1994; 18(4):259-65. PubMed ID: 7811656
[TBL] [Abstract][Full Text] [Related]
16. [Sedation with intravenous midazolam during upper gastrointestinal endoscopy--changes in hemodynamics, oxygen saturation and memory].
Mizuno J; Matsuki M; Gouda Y; Nishiyama T; Hanaoka K
Masui; 2003 Sep; 52(9):976-80. PubMed ID: 14531257
[TBL] [Abstract][Full Text] [Related]
17. Assessment of recovery in patients undergoing intravenous conscious sedation using bispectral analysis.
Sandler NA; Hodges J; Sabino M
J Oral Maxillofac Surg; 2001 Jun; 59(6):603-11; discussion 611-2. PubMed ID: 11381378
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction.
Platten HP; Schweizer E; Dilger K; Mikus G; Klotz U
Clin Pharmacol Ther; 1998 May; 63(5):552-60. PubMed ID: 9630828
[TBL] [Abstract][Full Text] [Related]
19. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
[TBL] [Abstract][Full Text] [Related]
20. Intranasal midazolam: a comparison of two delivery devices in human volunteers.
Dale O; Nilsen T; Loftsson T; Hjorth Tønnesen H; Klepstad P; Kaasa S; Holand T; Djupesland PG
J Pharm Pharmacol; 2006 Oct; 58(10):1311-8. PubMed ID: 17034653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
